Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.3 (
RNase T1
)
1,228
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have investigated the specific DNA and RNA requirements for rho-dependent transcription termination in vitro. As a model, we have used templates containing the rho-dependent terminator of the Escherichia coli trp operon, trp t'. Templates containing the trp t' region direct specific rho-dependent termination in vitro, with concomitant stimulation of the rho
NTPase
activity, and deletion of the trp t' region results in templates that do not induce rho-dependent termination or rho
NTPase
activity. Addition of
ribonuclease T1
to transcription reactions specifically eliminated transcription termination and rho
NTPase
activity. These results demonstrate the requirement for a specific RNA component within the trp t' transcript necessary for
NTPase
activation and rho-dependent transcription termination. Active transcription is not a prerequisite for rho
NTPase
activation; trp t' RNA (rho-terminated transcripts) and read-through transcripts, which contain the trp t' region, activated the rho
NTPase
when rho was added after inhibition of transcription. As is true for synthetic polynucleotides known to activate the rho
NTPase
, the trp t' region has few G residues. This reduces the potential for the formation of stable secondary structures in the RNA transcript, and may be one determinant of sites specifying rho-dependent termination of transcription. The implications of this are discussed in the light of the lack of significant sequence homologies between rho-dependent transcription termination sites.
...
PMID:Rho-dependent termination and concomitant NTPase activity requires a specific, intact RNA region. 619 48